PatientAccess

AstraZeneca Chairman Warns: Drug Tariffs Will Be Detrimental to Patients

1 month ago

In a striking statement, the chairman of AstraZeneca, Pascal Soriot, has raised alarms about the potential impact of proposed tariffs on medications, emphasizing that such measures would ultimately hurt patients in need of essential drugs. Speaking at an exclusive event, Soriot outlined the serious consequences that tariffs could impose on the pharmaceutical supply chain and healthcare access.

Roche's Bold $1 Billion Investment to Make Gene Therapies Affordable

7 months ago

In a groundbreaking move within the biotechnology sector, Roche has announced a remarkable investment of $1 billion aimed at making gene therapies more accessible and affordable. This high-stakes initiative comes in response to the widespread concern regarding the exorbitant costs associated with gene treatments, which have often barred patients from receiving potentially life-saving therapies.